| dc.description.abstract | Raccoon dog and fox amdoparvovirus (RFAV) has been reported in raccoon dogs and foxes, but
natural infection in domestic dogs has not previously been documented. During March-April 2026,
samples from affected Dobermann dogs from a kennel near Novi Sad, Serbia, were submitted for
laboratory investigation. After negative testing for canine adenovirus, canine coronavirus,
herpesvirus, parvovirus, distemper virus, influenza A virus, and leptospirosis, metagenomic
sequencing was performed on selected tissues, followed by bioinformatic analysis and targeted
RFAV PCR screening of additional outbreak-associated samples. Affected dogs had prolonged illness
characterized by conjunctivitis with ocular and nasal discharge, occasional blue eye appearance,
progressive weight loss, poor coat quality, biochemical evidence of hepatic injury, and neurologic
signs including paraplegia in advanced cases. Sequencing generated 434,220 reads and identified
multiple RFAV hits; pooled assembly produced a 4,799-bp consensus genome with approximately
97% similarity to known RFAV strains and genome organization consistent with the genus
Amdoparvovirus. RFAV DNA was subsequently detected by virus-specific PCR in a epidemiologically
linked dog and across diverse specimen types including blood, urine, kidney, spleen, brain, lung,
testicle, ileocecal lymph node, and throat swabs, whereas clinically healthy unrelated dogs were PCR negative. | en_US |
| dc.description.sponsorship | This research was supported by the European Union’s Horizon Europe Research and Innovation
Project Pipeline for Rapid Diagnostics of Emergency Transboundary Infectious Diseases (PREPARE-TID, grant
number 101137132). In addition, this study was also funded by the Provincial Secretariat for Higher Education
and Scientific Research Activity of Autonomous Province of Vojvodina, Republic of Serbia (Contract No.
003878144 2025 09418 003 000 000 001 04 004) and by the Ministry of Science, Technological Development and
Innovation of Republic of Serbia, Contract No: 451-03-33/2026-03/200031. | en_US |